These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4146701)

  • 41. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 43. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 44. Interaction of papaverine and isoproterenol in the vascular system of the dog and intestinal smooth muscle of the rabbit.
    Hansl NR; Zarlengo DG
    Clin Toxicol; 1977; 11(4):427-35. PubMed ID: 201425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 47. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 48. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 49. Adrenergic blocking properties of MJ 1999 and butoxamine on cardiac and vascular beta-receptors.
    Wilkenfeld BE; Levy B
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):218-32. PubMed ID: 5709786
    [No Abstract]   [Full Text] [Related]  

  • 50. Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).
    Somani P; Laddu AR
    J Pharmacol Exp Ther; 1969 Nov; 170(1):72-8. PubMed ID: 4390814
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
    Bassenge E; Doutheil U
    Arzneimittelforschung; 1970 Mar; 20(3):343-7. PubMed ID: 4392592
    [No Abstract]   [Full Text] [Related]  

  • 52. Assessment of relative actions of beta-adrenergic blocking drugs on heart rate and left ventricular ejection using a non-invasive method in patients with aortic Starr-Edwards prostheses.
    Crouchman MR
    Br Heart J; 1973 May; 35(5):475-9. PubMed ID: 4146054
    [No Abstract]   [Full Text] [Related]  

  • 53. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine).
    Levy B
    J Pharmacol Exp Ther; 1966 Mar; 151(3):413-22. PubMed ID: 4380047
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of RMI 81968, a combined alpha- and beta-adrenergic receptor blocking agent, on histamine-induced bronchoconstriction in the dog.
    Cheng HC; Reavis OK; Woodward JK
    Pharmacology; 1980; 20(2):111-4. PubMed ID: 6104338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
    Lish PM; Weikel JH; Dungan KW
    J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558
    [No Abstract]   [Full Text] [Related]  

  • 56. Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man.
    Lewis BS; Bakst A; Kitchiner D; Gotsman MS
    S Afr Med J; 1973 Jul; 47(27):1181-4. PubMed ID: 4146564
    [No Abstract]   [Full Text] [Related]  

  • 57. Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols.
    Large MS; Smith LH
    J Med Chem; 1980 Feb; 23(2):112-7. PubMed ID: 6102152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological actions of a new -adrenoceptor agonist, MJ-9184-1, in anaesthetized cats.
    Gwee MC; Nott MW; Raper C; Rodger IW
    Br J Pharmacol; 1972 Nov; 46(3):375-85. PubMed ID: 4144240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Nakao K; Takagi K
    Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
    Cuthbert MF; Owusu-Ankomah K
    Br J Pharmacol; 1971 Nov; 43(3):639-48. PubMed ID: 4400530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.